||||||IIII USOO5597809A United States Patent (19) 11) Patent Number: 5,597,809 Dreyer 45) Date of Patent: Jan
||||||IIII USOO5597809A United States Patent (19) 11) Patent Number: 5,597,809 Dreyer 45) Date of Patent: Jan. 28, 1997 (54) TREATMENT OF OPTIC NEURITIS Dreyer, E. B., et al., "Greater Sensitivity of Larger Retinal Ganglion Cells to NMDA-mediated Cell Death', 1994, (75) Inventor: Evan B. Dreyer, Chestnut Hill, Mass. Neuroreport, 5(5):629–31. Dreyer, E. B., et al., “HIV-1 Coat Protein Neurotoxicity 73) Assignee: Massachusetts Eye & Ear Infirmary, Prevented by Calcium Channel Antagonists', 1990, Science, Boston, Mass. 248:364-67. Elo, R., et al., "Serum Iron, Copper, Magnesium and Zinc 21 Appl. No. 264,728 Concentration in Chronic Pulmonary Tuberculosis during Chemotherapy with Capreomycin-Ethambutol-Rifampicin 22 Filed: Jun. 23, 1994 Combinations', 1970, Scand. J. Resp. Dis., 51:249-55. (51 Int. Cl." ................................. A01N 43/04 Figueroa, R., et al., “Effect of Ethambutol on the Ocular 52 U.S. Cl. ............................ 514/37; 514/145; 514/148; Zinc Concentration in Dogs”, 1971, Am. Rev. of Respiratory 514/224.8; 514/231.2: 514/233.2; 514/256; Disease, 104(4):592-94. 514/260; 514/277; 514/278; 514/299; 514/312; Hahn, J. S., et al., "Central Mammalian Neurons Normally 514/314; 514/317; 514/345; 514/469; 514/492; Resistant to Glutamate Toxicity are Made Sensitive by 514/493; 514/498; 514/501; 514/504; 514/530; Elevated Extracellular Ca': Toxicity is Blocked by the 514/601; 514/602; 514/608; 514/613; 514/616; N-methyl-D-aspartate Antagonist MK-801", 1988, Proc. 514/646; 514/647 Natl. Acad. Sci. USA, 85:6556-60.
[Show full text]